ERBB2 and breast cancer: Single cells from HER2+ BC had the highest proportion in BC-ImH and the lowest proportion in BC-ImM (BC-ImH (68.0%) versus BC-ImM (39.7%) versus BC-ImL (58.5%)) (p < 0.001) (Figure 8C).